Caxton Associates (UK)’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,660
Closed -$231K 769
2025
Q4
$231K Buy
+14,660
New +$262K ﹤0.01% 681
2025
Q3
Sell
-11,666
Closed -$241K 690
2025
Q2
$241K Sell
11,666
-2,320
-17% -$48.2K 0.01% 596
2025
Q1
$342K Buy
+13,986
New +$359K 0.01% 594

Other funds holding AMN

Caxton Associates (UK)'s AMN Position: Q1 2026 in Review

Caxton Associates (UK) sold out of AMN Healthcare (AMN) in Q1 2026, closing a stake of 14,660 shares — an estimated $231K sold.

Caxton Associates (UK) first reported a position in AMN in Q1 2025 and held it in 3 quarters. The position peaked at $342K in Q1 2025. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Caxton Associates (UK) reported no remaining AMN Healthcare position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 14,660 AMN Healthcare shares in Q1 2026, an estimated $231K.
  • Caxton Associates (UK) first reported a position in AMN Healthcare in Q1 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s AMN Healthcare position peaked at $342K in Q1 2025.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.